Intravitreal Conbercept Injection with and without Grid Laser Photocoagulation in the Treatment of Diffuse Diabetic Macular Edema in Real-Life Clinical Practice

Table 2

Best-corrected visual acuity and central retinal thickness outcome at month 12.

Characteristic	IVC group ()	Combined group ()
Mean BCVA letter score at month 12 ± SD	57.9 ± 9.4	53.5 ± 11.8
Mean CRT at month 12 ± SD, μm	342.1 ± 76.9	310.8 ± 81.0
Mean change in BCVA letter score from baseline to month 12
Mean ± SD	9.1 ± 4.5	7.5 ± 4.2
value	0.164
Mean CRT change from baseline to month 12 ± SD, μm
Mean ± SD	−145.1 ± 69.9	−168.5 ± 53.6
value	0.149
Categorized BCVA letter score outcome at month 12, (%)
Gain of ≥5	25 (80.6)	22 (73.3)
Gain of ≥10	14 (45.2)	10 (33.3)
Gain of ≥15	4 (12.9)	2 (6.7)

IVC: intravitreal conbercept; BCVA: best-corrected visual acuity; CRT: central retinal thickness; SD: standard deviation.
Independent -test.